{"id":909,"date":"2012-01-26T09:36:59","date_gmt":"2012-01-26T09:36:59","guid":{"rendered":"https:\/\/adreshe.com\/?p=909"},"modified":"2024-09-09T07:57:11","modified_gmt":"2024-09-09T07:57:11","slug":"a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries","status":"publish","type":"post","link":"https:\/\/adreshe.com\/en\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/","title":{"rendered":"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries"},"content":{"rendered":"<p>Iannazzo S, Carsi M, Chiroli S. &#8211; Appl Health Econ Health Policy 2012; 10(2): 127-38<\/p>","protected":false},"excerpt":{"rendered":"<p>Iannazzo S, Carsi M, Chiroli S. &#8211; Appl Health Econ Health Policy 2012; 10(2): 127-38<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[47,8],"tags":[],"class_list":["post-909","post","type-post","status-publish","format-standard","hentry","category-47","category-articoli"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries - Adres<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/adreshe.com\/en\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries - Adres\" \/>\n<meta property=\"og:description\" content=\"Iannazzo S, Carsi M, Chiroli S. &#8211; Appl Health Econ Health Policy 2012; 10(2): 127-38\" \/>\n<meta property=\"og:url\" content=\"https:\/\/adreshe.com\/en\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/\" \/>\n<meta property=\"og:site_name\" content=\"Adres\" \/>\n<meta property=\"article:published_time\" content=\"2012-01-26T09:36:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-09T07:57:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/adreshe.com\/wp-content\/uploads\/2025\/03\/AdRes.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/adreshe.com\/#\/schema\/person\/9099f9d808254da1a35de846dff135f5\"},\"headline\":\"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries\",\"datePublished\":\"2012-01-26T09:36:59+00:00\",\"dateModified\":\"2024-09-09T07:57:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/\"},\"wordCount\":25,\"publisher\":{\"@id\":\"https:\/\/adreshe.com\/#organization\"},\"articleSection\":[\"2012\",\"ARTICOLI\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/\",\"url\":\"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/\",\"name\":\"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries - Adres\",\"isPartOf\":{\"@id\":\"https:\/\/adreshe.com\/#website\"},\"datePublished\":\"2012-01-26T09:36:59+00:00\",\"dateModified\":\"2024-09-09T07:57:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/adreshe.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/adreshe.com\/#website\",\"url\":\"https:\/\/adreshe.com\/\",\"name\":\"Adres\",\"description\":\"Health Economics &amp; Outcomes Research\",\"publisher\":{\"@id\":\"https:\/\/adreshe.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/adreshe.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/adreshe.com\/#organization\",\"name\":\"Adres - Health Economic & Outcome Research\",\"url\":\"https:\/\/adreshe.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/adreshe.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/adreshe.com\/wp-content\/uploads\/2024\/01\/Logo-AdRes-rgb.png\",\"contentUrl\":\"https:\/\/adreshe.com\/wp-content\/uploads\/2024\/01\/Logo-AdRes-rgb.png\",\"width\":1754,\"height\":874,\"caption\":\"Adres - Health Economic & Outcome Research\"},\"image\":{\"@id\":\"https:\/\/adreshe.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/adreshe.com\/#\/schema\/person\/9099f9d808254da1a35de846dff135f5\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/adreshe.com\/en\/author\/ecappelluti_vr1q5683\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries - Adres","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/adreshe.com\/en\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/","og_locale":"en_US","og_type":"article","og_title":"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries - Adres","og_description":"Iannazzo S, Carsi M, Chiroli S. &#8211; Appl Health Econ Health Policy 2012; 10(2): 127-38","og_url":"https:\/\/adreshe.com\/en\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/","og_site_name":"Adres","article_published_time":"2012-01-26T09:36:59+00:00","article_modified_time":"2024-09-09T07:57:11+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/adreshe.com\/wp-content\/uploads\/2025\/03\/AdRes.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/#article","isPartOf":{"@id":"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/"},"author":{"name":"admin","@id":"https:\/\/adreshe.com\/#\/schema\/person\/9099f9d808254da1a35de846dff135f5"},"headline":"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries","datePublished":"2012-01-26T09:36:59+00:00","dateModified":"2024-09-09T07:57:11+00:00","mainEntityOfPage":{"@id":"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/"},"wordCount":25,"publisher":{"@id":"https:\/\/adreshe.com\/#organization"},"articleSection":["2012","ARTICOLI"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/","url":"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/","name":"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries - Adres","isPartOf":{"@id":"https:\/\/adreshe.com\/#website"},"datePublished":"2012-01-26T09:36:59+00:00","dateModified":"2024-09-09T07:57:11+00:00","breadcrumb":{"@id":"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/adreshe.com\/a-cost-utility-analysis-of-cinacalcet-in-secondary-hyperparathyroidism-in-five-european-countries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/adreshe.com\/"},{"@type":"ListItem","position":2,"name":"A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five european countries"}]},{"@type":"WebSite","@id":"https:\/\/adreshe.com\/#website","url":"https:\/\/adreshe.com\/","name":"Adres","description":"Health Economics &amp; Outcomes Research","publisher":{"@id":"https:\/\/adreshe.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/adreshe.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/adreshe.com\/#organization","name":"Adres - Health Economic & Outcome Research","url":"https:\/\/adreshe.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/adreshe.com\/#\/schema\/logo\/image\/","url":"https:\/\/adreshe.com\/wp-content\/uploads\/2024\/01\/Logo-AdRes-rgb.png","contentUrl":"https:\/\/adreshe.com\/wp-content\/uploads\/2024\/01\/Logo-AdRes-rgb.png","width":1754,"height":874,"caption":"Adres - Health Economic & Outcome Research"},"image":{"@id":"https:\/\/adreshe.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/adreshe.com\/#\/schema\/person\/9099f9d808254da1a35de846dff135f5","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/adreshe.com\/en\/author\/ecappelluti_vr1q5683\/"}]}},"_links":{"self":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/comments?post=909"}],"version-history":[{"count":1,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/909\/revisions"}],"predecessor-version":[{"id":910,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/909\/revisions\/910"}],"wp:attachment":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/media?parent=909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/categories?post=909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/tags?post=909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}